DAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk

Dow Jones

01/20

1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group Merck KGaA, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. Merck KGaA is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com)

(END) Dow Jones Newswires

January 20, 2026 05:03 ET (10:03 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2604199450"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604199450\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604199450?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604199450","market":"sh","top_or_hot":-1,"title":"DAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a>, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. <a href=\"https://laohu8.com/S/MKKGY\">Merck KGaA</a> is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 20, 2026 05:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDAVOS: U.S. Drug-Price Concerns Are Legitimate, Merck KGaA CEO Says -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-20 18:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a>, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. <a href=\"https://laohu8.com/S/MKKGY\">Merck KGaA</a> is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 20, 2026 05:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2604199450","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604199450","pubTimestamp":1768903380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group Merck KGaA, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. Merck KGaA is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","MKKGY":"Merck KGaA"},"translate_title":"达沃斯：默克公司首席执行官表示，对美国药品价格的担忧是合理的——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MKKGY":0.9},"content_text":"1003 GMT - Efforts by the U.S. government to bring down pricing for certain drugs are legitimate, Belen Garijo, departing chief executive of German life-sciences and chemicals group Merck KGaA, tells Bloomberg at the World Economic Forum in Davos, Switzerland. Several pharmaceutical companies recently agreed to lower prices that certain federal government programs and patients pay in agreement with the Trump administration. Merck KGaA is collaborating with the U.S. administration to find the right balance, Garijo says. Kai Beckmann is due to succeed Garijo as CEO on May 1. (mauro.orru@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 05:03 ET (10:03 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}